Israel - englanti - Ministry of Health

unipharm ltd, israel - levofloxacin as hemihydrate - tablets - levofloxacin as hemihydrate 500 mg - levofloxacin - levo is indicated in adults for the treatment of the following infections:• acute pyelonephritis and complicated urinary tract infections• chronic bacterial prostatitisin the below-mentioned infections, tavanic should be used only when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the treatment of these infections. • acute bacterial sinusitis• acute exacerbations of chronic obstructive pulmonaty disease including bronchitis• community-acquired pneumonia• complicated skin and soft tissue infections. levo may also be used to complete a course of therapy in patients who have shown improvement during initial treatment with intravenous levofloxacin.consideration should be given to official guidance on the appropriate use of antibacterial agents.

Israel - englanti - Ministry of Health

unipharm ltd, israel - losartan potassium - tablets - losartan potassium 100 mg - losartan - hypertension: lotan 100 is indicated for the treatment of hypertension. heart failure:lotan 100 is indicated for the treatment of heart failure, when treatment with an ace inhibitor is not appropriate. switching patients with heart failure who are stable on an ace inhibitor to lotan 100 is not recommended. renal protection in type-2 diabetic patients with proteinuria: lotan 100 is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine, end stage renal disease (need for dialysis or renal transplantation) or death; and to reduce proteinuria. reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy. lotan 100 is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death, stroke, and myocardial infarction in hypertensive patients with left ventricular hypertrophy. the benefit of lotan 100 on the primary deposite endpoint was largely driven by reduction in the risk of stroke.

Israel - englanti - Ministry of Health

unipharm ltd, israel - losartan potassium - tablets - losartan potassium 12.5 mg - losartan - heart failure: lotan 12.5 is indicated for the treatment of heart failure, when treatment with an ace inhibitor is no longer considered appropriate. switching patients with heart failure who are stable on an ace inhibitor to lotan 12.5 mg is not recommended

Israel - englanti - Ministry of Health

unipharm ltd, israel - losartan potassium - tablets - losartan potassium 50 mg - losartan - hypertension: lotan 50 mg is indicated for the treatment of hypertensionheart failure: lotan 50 mg is indicated for the treatment of heart failure, usually in addition to diuretics and/or digitalis, if use of an ace inhibitor is not appropriate.switching patients with heart failure who are stable on an ace inhibitor to lotan 50 mg is not recommended.renal protection in type-2 diabetic patients with proteinuria: lotan 50 mg is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine, end stage renal disease (need for dialysis or renal transplantation) or death; and to reduce proteinuria.reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy. lotan 50 mg is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death, stroke, and myocardial infarction in hypertensive patients with left ventricular hypertrophy.the benefit of lotan 50 mg on the primary deposite endpoint was largely driven by reduction in the risk of stroke.

Israel - englanti - Ministry of Health

unipharm ltd, israel - mirtazapine - tablets - mirtazapine 30 mg - mirtazapine - episode of major depression

Israel - englanti - Ministry of Health

unipharm ltd, israel - mirtazapine - tablets - mirtazapine 45 mg - mirtazapine - episode of major depression.

Israel - englanti - Ministry of Health

unipharm ltd, israel - memantine hydrochloride - tablets - memantine hydrochloride 10 mg - memantine - treatment of patient with moderate to severe alzheimer's disease.

Israel - englanti - Ministry of Health

unipharm ltd, israel - memantine hydrochloride - film coated tablets - memantine hydrochloride 20 mg - memantine - treatment of patient with moderately severe to severe alzheimer's disease.

Israel - englanti - Ministry of Health

unipharm ltd, israel - zopiclone - tablets - zopiclone 3.75 mg - zopiclone - hypnotic.

Israel - englanti - Ministry of Health

unipharm ltd, israel - zopiclone - tablets - zopiclone 7.5 mg - zopiclone - hypnotic when the disorder of insomnia is severe and disabling.